×
For best experience we recommend to activate Javascript in your browser.
FLT4 antibody (AA 1279-1283)
This Rabbit Polyclonal antibody specifically detects FLT4 in WB, IHC and IF. It exhibits reactivity toward Human.
Quick Overview for FLT4 antibody (AA 1279-1283) (ABIN871636)
Target
See all FLT4 Antibodies
FLT4
(Fms-Related Tyrosine Kinase 4 (FLT4))
Reactivity
All reactivities for FLT4 antibodies
Human
Host
All hosts for FLT4 antibodies
Rabbit
Clonality
All clonalities for FLT4 antibodies
Polyclonal
Conjugate
All conjugates for FLT4 antibodies
This FLT4 antibody is un-conjugated
Application
All applications for FLT4 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Product Details anti-FLT4 Antibody
(hide)
Binding Specificity
All epitopes for FLT4 antibodies
AA 1279-1283
Specificity
The antibody detects endogenous level of total VEGFR-3 protein.
Purification
Affinity purified
Immunogen
Peptide sequence around AA 1279-1283 (L-A-S-E-E) derived from Human VEGFR-3. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
Alternatives
(show)
Application Details
(hide)
Application Notes
Western blotting: 1:500-1:1000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C/-20 °C
Storage Comment
Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
Target Details for FLT4
(hide)
Target
FLT4
(Fms-Related Tyrosine Kinase 4 (FLT4))
Alternative Name
VEGFR-3
Background
Receptor for VEGFC. Has a tyrosine-protein kinase activity.
Molecular Weight
160 kDa
Gene ID
2324
NCBI Accession
NP_002011
UniProt
P35916
Pathways
RTK Signaling , Signaling Events mediated by VEGFR1 and VEGFR2 , VEGF Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat